Sugiura, Y., Machinami, R., Matsumoto, S., Kanda, H., Ae, K., Takazawa, Y., & Takeuchi, K. (2021). Prognostic value of CD34 expression status in patients with myxofibrosarcomas and undifferentiated pleomorphic sarcomas. Sci Rep.
Chicago-стиль цитированияSugiura, Yoshiya, Rikuo Machinami, Seiichi Matsumoto, Hiroaki Kanda, Keisuke Ae, Yutaka Takazawa, and Kengo Takeuchi. "Prognostic Value of CD34 Expression Status in Patients With Myxofibrosarcomas and Undifferentiated Pleomorphic Sarcomas." Sci Rep 2021.
MLA-цитированиеSugiura, Yoshiya, et al. "Prognostic Value of CD34 Expression Status in Patients With Myxofibrosarcomas and Undifferentiated Pleomorphic Sarcomas." Sci Rep 2021.
Предупреждение: эти цитированмия не могут быть всегда правильны на 100%.